SCHEMBL23957147

SCHEMBL23957147

Fc1ccc2c(c1)C=CC1(CNC1)O2

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 13/20 0.73
DRD2 P14416 1/20 0.51
HTR2A P28223 1/20 0.51
HTR2B P41595 1/20 0.43
HIF1A Q16665 4/20 0.34
EPAS1 Q99814 4/20 0.34
HDAC3 O15379 1/20 0.33
HDAC4 P56524 1/20 0.33
HDAC1 Q13547 1/20 0.33
HDAC7 Q8WUI4 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC10 Q969S8 1/20 0.33
HDAC11 Q96DB2 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
HDAC6 Q9UBN7 1/20 0.33
HDAC9 Q9UKV0 1/20 0.33
HDAC5 Q9UQL6 1/20 0.33
PTGS1 P23219 1/20 0.33
PTGS2 P35354 1/20 0.33
XDH P47989 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3413994 0.84 HTR2C (1.00) HTR2CDRD2HTR2AHTR2BHDAC3
Hydrochloric Acid SCHEMBL4512966 0.83 HTR2C (0.97) HTR2CDRD2HTR2AHTR2BHDAC3
SCHEMBL31543816 0.81 HTR2C (0.60) HTR2CDRD2HTR2AHTR2B
SCHEMBL6024450 0.73 HTR2C (0.54) HTR2CDRD2HTR2AHIF1AEPAS1
SCHEMBL537541 0.72 HTR2C (1.00) HTR2CDRD2HTR2AHTR2B
SCHEMBL20270447 0.67 HTR2C (0.81) HTR2CDRD2HTR2AHTR2B
SCHEMBL31235894 0.67 HTR2C (0.81) HTR2CDRD2HTR2AHTR2B
Hydrochloric Acid SCHEMBL3213611 0.64 HTR2C (0.79) HTR2CHTR2B
SCHEMBL7092152 0.63 HTR2C (0.80) HTR2CDRD2HTR2AHTR2B
SCHEMBL25341718 0.62 HTR2C (0.45) HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210330650-A1 SPIROCHROMANE DERIVATIVES RICHTER GEDEON NYRT. (HU) 2021-10-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210330650-A1 SPIROCHROMANE DERIVATIVES CHRNA7, CHRM3, ADRB3 HTR2C 217/4885DRD2 262/4885HTR2A 398/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.